Postmenopausal Women clinical trials

Explore recruiting postmenopausal women clinical trials.

Recruiting postmenopausal women studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Postmenopausal Women trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Is there an effect of local vaginal estrogen treatment on the hemostatic parameters in postmenopausal women?

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

REQUIRED DOSE OF CHOLECALCIFEROL IN THE MANAGEMENT OF VITAMIN D DEFICIENCY AND INSUFFICIENCY IN POSTMENOPAUSAL WOMEN

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-blind, Parallel-group, Active-controlled Study to Compare the Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of MAB-22 Versus Prolia® Sourced from the European Union in Postmenopausal Women with Osteoporosis

Czechia, Bulgaria, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

BRCA-P: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, International Phase 3 Study to Determine the Preventive Effect of Denosumab on Breast Cancer in Women Carrying a BRCA1 Germline Mutation

Spain, Germany, Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Resistance training and rapamycin to enhance bone formation in postmenopausal women (STRONGBONE)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Targeting mTOR with everolimus and/or physical training for preventing postmenopausal bone loss and accelerated skeletal aging. The RapaLoad study.

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Postmenopausal Women trials by city

Postmenopausal Women in Toronto Postmenopausal Women in Vancouver Postmenopausal Women in Montreal Postmenopausal Women in Calgary Postmenopausal Women in Edmonton Postmenopausal Women in Ottawa Postmenopausal Women in Winnipeg Postmenopausal Women in Quebec City Postmenopausal Women in Hamilton Postmenopausal Women in Kitchener Postmenopausal Women in London Postmenopausal Women in Halifax Postmenopausal Women in New York Postmenopausal Women in Los Angeles Postmenopausal Women in Chicago Postmenopausal Women in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease